Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Management of high-risk breast lesions found on mammogram or ultrasound: the value of contrast-enhanced MRI to exclude malignancy. Clin Imaging 2018;49:174-180

Date

03/24/2018

Pubmed ID

29571172

DOI

10.1016/j.clinimag.2018.03.011

Scopus ID

2-s2.0-85044108709 (requires institutional sign-in at Scopus site)   7 Citations

Abstract

PURPOSE: To evaluate the performance of magnetic resonance imaging (MRI) to exclude malignancy in biopsy-proven high-risk breast lesions prior to surgical excision.

MATERIAL AND METHODS: Breast MRIs performed after a core needle biopsy (CNB) yielding high-risk pathology were evaluated for the presence of suspicious enhancement. The diagnostic performance of MRI to exclude malignancy was calculated.

RESULTS: The average reader sensitivity, specificity, negative predictive value, positive predictive value and accuracy of MRI were 92%, 51%, 98%, 22% and 56%, respectively.

CONCLUSION: Lack of enhancement on MRI at the site of a high-risk lesion was useful for excluding malignancy.

Author List

Hammersley JA, Partridge SC, Blitzer GC, Deitch S, Rahbar H

Author

Sarah G. Deitch MD Assistant Professor in the Radiology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Aged
Biopsy
Biopsy, Large-Core Needle
Breast
Breast Neoplasms
Contrast Media
Female
Humans
Magnetic Resonance Imaging
Mammography
Middle Aged
Retrospective Studies
Sensitivity and Specificity
Ultrasonography